1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,114 | 0,142 | 21.05. | |
| 0,121 | 0,140 | 21.05. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 23.04. | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.04. | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| 23.04. | BRII-B (02137): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 1 | HKEx | ||
| 23.04. | BRII-B (02137): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | BRII-B (02137): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | BRII-B (02137): (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT ... | - | HKEx | ||
| 23.04. | BRII-B (02137): 2025 ANNUAL REPORT | - | HKEx | ||
| 16.04. | BRII-B (02137): INSIDE INFORMATION IN RELATION TO ARBITRATION PROCEEDINGS | 2 | HKEx | ||
| 19.03. | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results | 259 | PR Newswire | Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts
Increasing Discovery Efforts to Drive Long-term Value Creation
Strong Cash Position Supporting Strategic... ► Artikel lesen | |
| 19.03. | BRII-B (02137): NOTIFICATION OF 2025 PFIC STATUS | - | HKEx | ||
| 19.03. | BRII-B (02137): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 | - | HKEx | ||
| 09.03. | BRII-B (02137): DATE OF BOARD MEETING | 1 | HKEx | ||
| 21.08.25 | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results | 196 | PR Newswire | Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy
Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOGEN | 162,88 | -0,15 % | Biogen, Denali discontinue Parkinson's drug after trial fails | ||
| ILLUMINA | 123,84 | -0,63 % | Illumina adds former Labcorp CEO to board of directors | ||
| NANOREPRO | 1,650 | +0,61 % | NanoRepro: Mit Elan gestartet | "Wir sind auf einem guten Weg", sagt Lisa Jüngst, CEO von NanoRepro, am Ende ihrer Präsentation auf der Frühjahrskonferenz in Frankfurt. Die Aufgabenstellung könnte dabei ambitionierter kaum sein. Immerhin... ► Artikel lesen | |
| CYTODYN | 0,284 | 0,00 % | CytoDyn Inc.: CytoDyn to Present at the LD Micro Invitational XVI | ||
| IMMUNIC | 10,025 | -5,69 % | EQS-News: Immunic AG: Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors | Issuer: Immunic AG
/ Key word(s): Personnel
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
19.05.2026 / 12:30... ► Artikel lesen | |
| ADAPTIVE BIOTECHNOLOGIES | 11,705 | -1,93 % | Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results | SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics... ► Artikel lesen | |
| GENPREX | 0,810 | -0,60 % | Genprex, Inc.: Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa Gene Therapy in Combination with Immunotherapies to Treat Cancer | Japanese Patent Covers Acclaim-3 Clinical Trial Combining REQORSA Gene Therapy with Genentech, Inc.'sTecentriq®
AUSTIN, Texas, Feb. 23, 2026 /PRNewswire/ -- Genprex... ► Artikel lesen | |
| PERSONALIS | 7,038 | -0,79 % | US Agency Broadens Coverage Of Personalis Breast Cancer Test | ||
| VITROLIFE | 9,985 | -0,55 % | Dividendenbekanntmachungen (06.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCELLERON INDUSTRIES AG CH1169360919 1,5 CHF 1,6376 EUR ALSEA SAB DE CV MXP001391012 1 MXN 0,0492 EUR ALZCHEM GROUP AG DE000A2YNT30 - 2... ► Artikel lesen | |
| PLURI | 4,660 | -100,00 % | Pluri Inc.: Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement | HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. ("Pluri" or the "Company") (Nasdaq, TASE: PLUR), a biotechnology company leveraging a proprietary cell-based platform across multiple commercial... ► Artikel lesen | |
| LEGEND BIOTECH | 24,200 | 0,00 % | GENSCRIPT BIO: Legend Biotech Corporation Presents Multiple Research Findings at ASCO Annual Meeting in the US | ||
| ENVERIC BIOSCIENCES | 2,190 | -1,35 % | Enveric Biosciences, Inc. - 10-Q, Quarterly Report | ||
| ENANTA | 11,800 | +1,72 % | Enanta Pharmaceuticals, Inc.: Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026 | Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that... ► Artikel lesen | |
| NATURAL ALTERNATIVES INTERNATIONAL | 2,080 | +0,97 % | Natural Alternatives International Inc: Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results | CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements... ► Artikel lesen | |
| MONOPAR THERAPEUTICS | 49,400 | -8,18 % | Monopar reports positive Wilson disease trial data publication |
BRII BIOSCIENCES LTD gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,145 Euro und damit +10,69 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRII BIOSCIENCES LTD finden Sie auf Wallstreet Online.